| Dr Emily Mae Potter, PHARMD | |
|
4101 S 4th St, Leavenworth, KS 66048-5014 | |
| (913) 682-2000 | |
| Not Available |
| Full Name | Dr Emily Mae Potter |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 4101 S 4th St, Leavenworth, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588943138 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Mae Potter, PHARMD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: (913) 682-2000 | Dr Emily Mae Potter, PHARMD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: (913) 682-2000 |
News Archive
The Coalition for Pulmonary Fibrosis announced today a nationwide advertising campaign to spread the word about Pulmonary Fibrosis is underway in an untraditional setting – on the nation's interstates. Together, a billboard ad and truck ads are part of a nationwide campaign to raise eyebrows and awareness of the deadly lung disease.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Thousands of rare diseases cumulatively affect millions of people across the globe, yet because each case is so rare doctors struggle to accurately diagnose and effectively treat individual patients. Every time a patient with an unspecified disorder walks into a new clinic or shows up in an emergency room, doctors must start from scratch. The patients often go through years of such experiences before they ever get a diagnosis.
A team of researchers from the National University of Singapore (NUS) has developed a novel prosthetic heart valve, known as VeloX, which can be implanted through a small incision for the treatment of a serious heart valve disorder called mitral regurgitation. This is a condition in which the mitral valve on the left side of the heart does not close properly. The device is particularly beneficial to patients who are of high surgical risk or are unsuitable for existing clinical interventions.
Flexible Stenting Solutions Inc. ("FSS"), a leading developer of next generation peripheral arterial and biliary stents, received 510(k) clearance for the FlexStent® Biliary Self Expanding Stent System.
› Verified 4 days ago
Dr. Roselle Marban Schanker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 | |
Heather M Reeves, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2107 S 4th St, Leavenworth, KS 66048 Phone: 913-651-6134 Fax: 913-651-4004 | |
Dr. Brandon Utter, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 785-218-1415 | |
Mr. Richard Brett Schneider, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4872 | |
Chris Charles Henington, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Dwight Eisenhower Va Medical Center, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-6944 | |
Dr. Mark Leo Wilson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5049 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4810 | |
Richard Earl Hoatson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5000 S 13th St, Leavenworth, KS 66048 Phone: 913-727-4854 |